Chapter 11 - Marijuana

Cannabis Sativa

  • hemp plant

    • source of fiber

    • marijuana - leafy top portion

    • hashish - dust of plant resin

  • used in other cultures and as a drug for centuries

  • not used as a drug in the US until the early 20th century

History

  • stone age - used for fiber

  • 2800 BC - used medicinally in China

  • one of five sacred plants in India

  • 10th & 11th century - spread to Middle East & North Africa

  • 1800s - medical use explored in Great Britain & France

  • 1960s - marijuana becomes popular in Europe

  • in the New World

    • hemp raised for fiber in Chile, Virginia, and New England by 1629

    • some medical use in the 1800s

    • little recreational use until the 1920s, coincident with Prohibition

    • smoking marijuana was introduced to the USA in the 1920s

Controlling Marijuana

  • 1920s - lots of use in New Orleans

  • 1927 - Louisiana outlawed possession and sale

  • 1930 - 16 states prohibited marijuana

  • 1937 - nearly all states prohibited marijuana

  • 1937 - marijuana tax act

Committee Reports

  • 1944 - LaGuardia Commission

    • marijuana use not particularly harmful

    • produces mental confusion, excitement, laughter, and anxiety

  • later reports in India, Britain, Canada, & US → similar conclusions

    • 1968 - Baroness Wootton Report (Great Britain)

    • 1972 -

      • Canadian Govt’s LeDain Commission

      • Marijuana: A Signal of Misunderstanding (US)

    • 1982 - 9th Report to Congress

    • 1984 - Drug Abuse & Drug Abuse Research

  • recommendations to approve use for treatment

    • 1988 - Britain’s House of Lords

    • 1999 - US National Academy of Sciences

      • pain relief, nausea/vomiting, appetite stimulation

    • 2002 - Cannabis: our position for a Canadian Public Policy

      • amend laws to allow compassionate medical access

      • license individuals to sell and produce cannabis

      • amnesty for those convicted of possession under current/past legislation

Epidemiology

  • most widely used illicit drug

  • third-most-used recreational drug

Who Uses Marijuana?

  • most prevalent

    • young adults

    • teenagers

  • men more likely than women

  • use varies by ethnic group:

    • Native Americans > Blacks > Whites > Hispanics

  • fewer people than in the 70s

Marijuana Usage Laws by State

  • nearly half of states have legalized recreational marijuana use

  • only about 1 in 10 Americans say marijuana use should not be legal at all

Views on Legalization

  • can differ by race, ethnicity, age, partisanship

  • public opinion - uptick 70s-2020s favoring legalization and downturn on making illegal

Cannabis Dispensaries

  • more concentrated where laws allow medicinal & recreational use

A Gateway?

  • most marijuana users don’t become heroin addicts

  • high-school students

    • alcohol use → marijuana use

    • 90% of crack users previously used marijuana

  • frequent marijuana users were 140 times more likely to use other illicit drugs

  • modern research supports a “common risk” model more than a true “gateway model”

Methods of Use

  • methods of use

    • eat

    • drink

    • chew

    • smoke

  • historically

    • marijuana & hashish were ingested in liquid and food form

    • people have also chewed marijuana leaves

  • most common in US today: smoking

    • very efficient for absorption

    • variety of methods

Active Ingredients

  • > 400 chemical compounds

  • > 60 cannabinoids are unique

  • delta-9-tetrahydrocannabinol

    • most effective

  • other cannabinoids

    • include cannabidiol and cannabinol

    • may be biologically active

    • may modify THC effects

Potency

  • lower THC content in American-grown marijuana

    • currently 5-6% THC

  • hashish shows similar variability

  • hash oil

    • concentrated marijuana extract

    • ~20% THC

    • can contain up to 60%

Pharmacokinetics

  • absorption

    • depends most on mode of consumption

    • smoking

      • most rapid

      • onset in minutes

        • peak levels 30-60 min later

    • oral ingestion

      • slower

      • less efficient

      • onset in an hour

        • peak levels 2-3 hours

  • distribution, metabolism, excretion

    • concentrated in brain, lungs, kidney, and liver

    • crosses the placenta

    • plasma levels of THC decrease quickly

    • THC deposited in organ tissue, especially those with fatty material

    • metabolized slowly in liver and other organs

      • most metabolites excreted in 1 week

      • some detachable for > 30 days

THC Mechanisms of Action

  • slows activity of several neurotransmitters

    • ACH

    • I-glutamate

    • GABA

    • Noradrenalin

    • Dopamine

    • Serotonin

  • enhances activation of movement

    • facilitates release of serotonin

    • → changes in dopamine system

Endogenous THC?

  • brain receptors: CB1 & CB2

    • CB1 receptors control memory, cognition, movement, & mood

    • CB2 receptors are in the immune system

  • endogenous chemicals acting on CB receptors

    • anandamide

    • 2-arachiconoyl-glycerol (2-AG)

Tolerance & Dependence

  • tolerance

    • clearly present in animal studies

    • less obvious in humans; inconsistent findings

    • tolerance is more likely if high doses are taken over a longer time

  • dependence

    • some argue that there is no significant withdrawal syndrome

    • other identify withdrawal syndrome:

      • sleep disturbance, nausea, irritability, and restlessness

      • most likely to occur following sustained, heavy use

  • physical dependence due to social use is rare

    • most doubted it existed until 1970s

  • 1970-80s

    • cessation of high, chronic use → withdrawal

      • ~210 mg THC/day

    • symptoms

      • irritability, restlessness, decreased appetite, sleep problems, sweating, tremor, nausea, vomiting, & diarrhea

  • 1999

    • withdrawal seen after 4 days of smoking 4 joints/day

      • 3.1% THC content

      • mild

  • most with marijuana dependence abuse other drugs

Physiological Effects

  • acute effects

    • bloodshot eyes, sluggish pupils

    • increased heart rate, blood pressure

    • decreased movement

    • high doses: decreased REM sleep

  • longer-term effects

    • respiratory

      • reversible airway obstruction

      • marijuana delivers more tar and carcinogens than tobacco

    • no damaging effects on heart of immune system in healthy users

    • reproduction

      • decreased sperm & motility

      • nonovulatory menstrual cycles

      • risk of premature birth, lower birth weight, shorter baby body length

      • risk of childhood cancer & ADHD

Psychological Effects

  • behavioral

    • decreased movement

    • increased talkativeness

    • feelings of relaxation

    • impaired driving ability

  • cognitive effects

    • impaired short-term memory

      • decreased ability to concentrate

    • perception that time passes more slowly

  • emotional effects

    • improved mood

    • intensity of euphoria is dose-related

    • negative feelings are common

  • social/environmental effects

    • doesn’t enhance social skills

    • doesn’t cause increased aggression

    • probably doesn’t account for amotivational syndrome

Therapeutic Uses

  • brief therapeutic use history

    • Shen Nung

    • childbirth

    • 1800s

      • mental illness, rheumatism, pain, rabies, cholera

    • 1930s: in over-the-counter medicines

      • stomach pain, restlessness, coughing

    • currently, synthetic THC:

      • Dronabinol (Marinol)

      • Nabilone (Cesamet)

      • Sativex (oral spray)

      • synthetics do not give rapid effect of smoking marijuana

  • current medical uses

    • nausea & vomiting due to cancer therapy

    • Cachexia (weight loss, muscle loss, and inflammation even when eating is normal)

    • Glaucoma (but limited evidence it actually reduced intraocular pressure)

Therapeutic Uses - 2017 Report

  • 2017 National Academies of Sciences report supports use of marijuana for:

    • substantial evidence of effectiveness

      • reducing chronic pain in adults

      • antiemetic for chemotherapy-induced nausea and vomiting

      • improving multiple sclerosis (MS) spasticity symptoms

    • moderate evidence of effectiveness

      • improving short-term sleep outcomes in various sleep disturbances

    • limited evidence of effectiveness for

      • increasing appetite and decreasing weight loss associated with HIV/AIDS

      • improving clinician-measured MS spasticity symptoms

      • improving symptoms of Tourette syndrome

      • improving anxiety symptoms in social anxiety disorders

      • improving symptoms of PTSD

  • report also indicated that conclusions fo rmedical use are often based on limited data

    • state laws that allow medical use could facilitate future research

    • regulatory barriers, including schedule I classification, impede research

  • May 2024: DEA issued notice of proposed rulemaking indicating FDA intends to transfer marijuana from Schedule I to Schedule III